Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Express Scripts
QuintilesIMS
Fuji
UBS

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 8,119,116

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,119,116
Title:Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
Abstract: The present invention relates to methods of treating a cancerous tumor using selective inhibitors of ATP production. The present invention also relates to pharmaceutical preparations comprising such inhibitors and methods for administering them intraarterially directly to a tumor, as well as methods for identifying compositions that selectively inhibitor ATP production for use in the invention.
Inventor(s): Ko; Young Hee (Owings Mills, MD), Geschwind; Jean-Francois (Potomac, MD), Pedersen; Peter L. (Columbia, MD)
Assignee: John Hopkins University School of Medicine (Baltimore, MD)
Application Number:12/355,115
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,119,116
Patent Claims:see list of patent claims

Details for Patent 8,119,116

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial John Hopkins University School of Medicine (Baltimore, MD) 2021-09-13 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Medtronic
QuintilesIMS
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.